Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study

The incident user design in comparative effectiveness research

(2012) Eric S. Johnson et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France

(2012) Nicholas Moore et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: A ‘proof of concept,’ open label study

(2011) Vitor Hugo Machado et al.   EPILEPSIA

The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis

(2011) Maja Mockenhaupt   Expert Review of Clinical Immunology

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

(2010) B Sassolas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment

(2009) Ilgen Ertam et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

(2007) Jürgen Schneck et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY